Liquipel Demonstrates the Latest in Liquid Protection Nanotechnology at SXSW

Posted on by

AUSTIN, TX--(Marketwire - Mar 13, 2013) - SOUTH BY SOUTHWEST (SXSW) -- Liquipel, LLC, makers of the award-winning Watersafe nanotechnology that protects your electronics from accidental water damage, will be at the Empire Garage and Control Room during South by Southwest. They will be showcasing their newly debuted Liquipel 2.0 nanocoating technology for mobile phones, headphones, microphones and more.

Liquipel will demonstrate the Liquipel 2.0 technology, which represents the latest in nanocoating science, technology and manufacturing process with marked improvements on durability, corrosion resistance and water protection from its predecessor. Liquipel's patent-pending process creates a liquid-repellant coating, that is microscopic and forever lasting because the coating becomes a part of the device. The coating is virtually untraceable and will not affect, nor compromise the look, feel and performance of the device.

"We are committed to getting this revolutionary technology in the hands of consumers everywhere," said Kevin Bacon, co-founder and chief operating officer of Liquipel. "This year we expanded our portfolio of products, and through Liquipel 2.0, we are delivering on our promise to advance our technology and products."

Where to find Liquipel Liquipel staff will be at the Empire Garage and Control Room (606 East 7th St. Austin, TX 78702) from March 12-16 from 1pm-6pm. For appointments, please email liquipel@socialradius.com.

About LiquipelLiquipel, LLC is the sole owner and licensor of Liquipel, an award-winning formulation and manufacturing process that uses nanotechnology to make smartphones and other devices Watersafe from accidental exposure to water and other liquids. Since its debut at the Consumer Electronics Show 2012, it has won an Edison Award, a FierceWireless Fierce 15 Award, was named by Popular Science the Grand Award Winner in the Gadgets Category in the magazine's "Best of What's New" issue, and has also been included in Entrepreneur Magazine's "100 Brilliant Companies" list. For more information and videos, please visit Liquipel's website, and follow us on Facebook and Twitter. To contact Liquipel, LLC, email info@liquipel.com.

See more here:

Liquipel Demonstrates the Latest in Liquid Protection Nanotechnology at SXSW

In Manifesto, Mexican Eco-Terrorists Declare War on Nanotechnology

Posted on by

Over the past two years, Mexican scientists involved in bio- and nanotechnology have become targets. Theyre not threatened by the nations drug cartels. Theyre marked for death by a group of bomb-building eco-terrorists with the professed goal of destroying human civilization.

The group, which goes by the name Individualidades Tendiendo a lo Salvaje (ITS), posted its manifesto to anarchist blog Liberacion Totallast month. The manifesto takes credit for a failed bombing attempt that month against a researcher at the Biotechnology Institute at the National Autonomous University of Mexico. And the group promises more.

We have said it before, we act without any compassion in the feral defense of Wild Nature, the manifesto states. Did those who modify and destroy the Earth think their actions wouldnt have repercussions? That they wouldnt pay a price? If they thought so, they are mistaken. The group threatens more bombings against Mexican scientists because they must pay for what they are doing to the Earth.

A violent fringe group with anarcho-primitivist views its name roughly translates to Individuals Tending to Savagery, although Tending to the Wild might be more exact ITS sees technology and civilization as essentially doomed and leading humanity to an ecological catastrophe. Technology should be destroyed; humans should revert to a hunter-gatherer lifestyle; and all of this, ITS says, is for our own good. Nanotechnology is a particular scourge: Self-replicating nanobots will one day escape from laboratories to consume the Earth; and weaponization of nanotech is inevitable.

The group first attracted attention in August 2011, when a package bomb mailed to the Monterrey Institute of Technology and Higher Education in Mexico City exploded, seriously injuring a robotics researcher and bursting the eardrum of a computer scientist. An earlier version of ITSs manifesto was found charred among the debris. Police have yet to make arrests in the case.

Late last month, ITS claimed responsibility for the 2011 shooting death of a biotechnology researcher, also of the National Autonomous University, boasting that Ernesto Mendez Salinas murder was the groups first fatality. But there are reasons to doubt the claim. ITS is lateto claim responsibility, and police believe the murder occurred during an attempted carjacking unrelated to the group. But at the very least, ITS wants to send the message that its willing to kill for its agenda.

ITS is nowhere near as deadly as the narco-terrorism that has plagued Mexico for years. Its claiming responsibility for seven bomb attempts that have injured three people and killed no one. Its also suspected of mailing two unclaimed bombs that exploded during shipping in the same period, injuring a total of four people. The most recent bomb exploded on Feb. 21 inside a mailbox, injuring a maintenance worker.

If all this sounds like an updated, Mexican version of the Unabomber, it should. According to Roger Griffin, a political scientist at Oxford Brookes University and author ofTerrorists Creed, the manifestos language has very strong parallels to the anti-technology pamphletIndustrial Society and Its Future byTed Kaczynski.

Kaczynski became persuaded that the technocracy was destroying the world, Griffin tells Danger Room. He became a radical ecologist, he lived in the wild, he lived in a hut, he read people like [technology critic] Jacques Ellul, and anarchists, and a whole load of stuff. And against the background of the 1960s hippie rediscovery of the mystic relationship with the environment, he developed a lone wolf version of ITS.

Two intersecting trends appear to account for the new wave of attacks on Mexican scientists: booming research in nanotechnology, and spillover violence from the drug wars.Along with other Latin American countries that have invested in the field Brazil and Argentina, in particular Mexico views nanotechnology as a pathway to a more powerful research and industrial base,Natures Leigh Phillipswrote in August. According to Nature, the boom coincided with the spread of a violent eco-anarchist philosophy among some radical groups.

See the rest here:

In Manifesto, Mexican Eco-Terrorists Declare War on Nanotechnology

EcoSynthetix and Waterloo Institute for Nanotechnology Partner to Investigate New Applications for Bio-based Materials

Posted on by

BURLINGTON , ON, March 13, 2013 /CNW/ - EcoSynthetix Inc. (ECO.TO) and the Waterloo Institute for Nanotechnology at the University of Waterloo have joined forces through an industrial partnership to collaborate on new applications for EcoSynthetix' EcoSphere technology. The five-year agreement will be jointly funded through an EcoSynthetix and NSERC (National Sciences and Engineering Research Council) Collaborative Research and Development Grant. The project matches the scientific expertise from the University of Waterloo in macromolecular science with the sustainability benefits of EcoSphere bio-based nanoparticles which are based on green chemistry. The goal of the project is to broaden the scientific knowledge base of the EcoSphere technology to support its introduction into new application areas.

"As a global centre of excellence for nanotechnology research, this project represents a great opportunity for our institute, faculty and students at the University, to collaborate with a local innovator to further our understanding of the technology and its potential applications," said Dr. Arthur J. Carty , Executive Director of the Waterloo Institute for Nanotechnology ("WIN") and an independent director of the board of EcoSynthetix. "Nanotechnology is a leading-edge, enabling technology that holds the promise of a lasting economic benefit for jobs and investment in the materials, energy and healthcare sectors. EcoSynthetix's innovative nanotechnology has the potential to impact a wide-array of markets that would benefit from a sustainable alternative to petroleum-based products."

"This ECO-WIN collaboration involves four professors and eight graduate students at the Waterloo Institute for Nanotechnology and is a great example of how industry and universities can work together to advance an exciting new area of science to benefit the community," said Dr. Steven Bloembergen , Executive Vice President, Technology of EcoSynthetix. "Our EcoSphere technology is already commercial and providing sustainable benefits in three separate markets today. Our team's primary focus at this stage is near-term product development and product enhancements of carbohydrate-based biopolymers. By working with the Institute of Nanotechnology to deepen our understanding of the basic science, we can identify new future applications that could benefit from our sustainable biobased materials."

The EcoSphere technology is being commercially utilized as biobased latex products providing alternatives to petroleum-based binders in the coated paper and paperboard market. The goal of this project is to generate a greater understanding of the properties of EcoSphere biolatex binders by establishing a knowledge base that could enable tailor-made novel particles with the desired properties for a given application. The project team will be chemically modifying the nanoparticles and then characterizing how the properties of the novel particles are affected by these changes.

About EcoSynthetix Inc. (www.ecosynthetix.com) EcoSynthetix Inc. is a renewable chemicals company specializing in biobased products that can be used as inputs in industrial manufacturing for a wide range of consumer products. The Company's products offer a reduced carbon footprint and are marketed primarily on the basis of lower cost, stable pricing and equal or superior performance. EcoSynthetix' lead products, EcoSphere biolatex binders, are used commercially by a number of the global top 20 manufacturers in the coated paper and paperboard industry.

About the Waterloo Institute for Nanotechnology The Waterloo Institute for Nanotechnology is an interdisciplinary research institute at the University of Waterloo, Ontario, Canada focused on science and engineering at the atomic scale, which entails the design, fabrication, and exploitation of materials and structures where dimensions are measured in billionths of a meter (10-9m).

The extraordinary range of possibilities offered by nanotechnology is based on the fact that the properties of materials change - sometimes radically - when their size approaches that of a few tens or hundreds of atoms. By taking advantage of the unique phenomena which predominate at the atomic-scale, the institute's scientists and engineers are discovering and developing nano-materials, nano-electronics, nano-instrumentation and nano-biosystems that will fundamentally change the world.

For more information visit the website at: http://www.uwaterloo.ca/institute-nanotechnology.

Forward Looking Statements Certain statements in this Press Release constitute "forward looking" statements that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, objectives or achievements of the Company, or industry results, to be materially different from any future results, performance, objectives or achievements expressed or implied by such forward looking statements. These statements reflect our current views regarding future events and operating performance and are based on information currently available to us, and speak only as of the date of this Press Release. These forward looking statements involve a number of risks, uncertainties and assumptions and should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such performance or results will be achieved. Those assumptions and risks include, but are not limited to, the fact that our results of operations and business outlook are subject to significant risk, volatility and uncertainty. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward looking statements, including the factors identified in the "Risk Factors" section of the Company's Annual Information Form dated March 30, 2012 . Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described in this Press Release as intended, planned, anticipated, believed, estimated or expected. Unless required by applicable securities law, we do not intend and do not assume any obligation to update these forward looking statements.

SOURCE: EcoSynthetix Inc.

See the original post:

EcoSynthetix and Waterloo Institute for Nanotechnology Partner to Investigate New Applications for Bio-based Materials

Nanotechnology in Energy Applications

Posted on by

NEW YORK, March 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Nanotechnology in Energy Applications http://www.reportlinker.com/p01119540/Nanotechnology-in-Energy-Applications.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Nanotechnology

INTRODUCTION

STUDY BACKGROUND

Nanotechnology is increasingly impacting the U.S. and world energy balance, both on the supply and demand sides. On the supply side, nanotechnology is being used to optimize production from existing energy sources (e.g., crude petroleum) and to exploit new sources such as heavy oil, liquefied coal and solar energy (including using solar energy to produce hydrogen). Nanotechnology is also improving and opening new possibilities for the transmission and storage of energy, especially electricity and possibly hydrogen in the future.

On the supply side, nanotechnologies have the potential to reduce energy consumption by making it possible to manufacture lighter and/or more energy-efficient cards and appliances. Nanotechnologies can also be used to improve energy efficiency in buildings.

STUDY GOALS AND OBJECTIVES

This report is an updated edition of a BCC report first published in 2007, whose goal is to identify and quantify the market for nanoscale materials and devices that are used to generate or conserve energy. Specific objectives include the following:

Identifying nanoscale materials and devices that currently are or in the future could be used in energy production or conservation applications. Analyzing and predicting trends in the most likely application(s) for each of these materials and devices. Projecting the resulting market for specific nanoscale materials and devices. Estimating the potential net impact of nanoscale materials and devices on the global energy balance. Drawing attention to manufacturers of renewable energy systems and associated advanced materials and devices that are most likely to benefit from the trends identified above.

INTENDED AUDIENCE

Continued here:

Nanotechnology in Energy Applications

Doctor to speak about integrative East-West medicine

Posted on by

Integrative East-West medicine can optimize the quality of life for patients with cancer, according to Dr. Malcolm Taw, assistant clinical professor of medicine at the UCLA Center for East-West Medicine.

The techniques can treat symptoms or side effects commonly associated with chemotherapy, radiation therapy and surgery, he said. These side effects can include pain, nausea, fatigue, insomnia, peripheral neuropathy, vasomotor hot flashes, lymphedema, chemo brain and anxiety, he said.

On Monday, Taw will present Cancer Care and Wellness through Integrative East-West Medicine at the Cancer Support Community, 530 Hampshire Road, Westlake.

Integrative East-West medicine is a health care paradigm that brings together the best of both conventional western biomedicine with traditional Chinese medicine to optimize patient care and outcomes, Taw said.

Perhaps the biggest myth about integrative East-West medicine is that there is no evidence in the medical literature for the treatments that we offer for our patients.

This may stem from the lack of understanding and experience about these therapies, such as acupuncture, he said.

However, there is actually an extensive amount of research about acupuncture describing its physiological mechanisms within the human body and demonstrating its benefit for various symptoms and conditions, Taw said.

Board certified by the American Board of Internal Medicine and the National Certification Commission for Acupuncture and Oriental Medicine in Oriental Medicine, Acupuncture and Chinese Herbology, Taw has treated patients with cancer, usually in collaboration with their oncologists and other health care providers, during different stages of the cancer process.

He has completed fellowships in integrative medicine at the UCLA Center for East-West Medicine and through the Bravewell Collaborative/University of Arizona Center for Integrative Medicine. Taw also has a Master of Science in Oriental Medicine and postdoctoral training through the National Institutes of Health-supported K30 Program in Translational Investigation at UCLA.

Dr. Taw is unique in his experience of both east and west medicine, said Tricia Lethcoe, a marriage and family therapist intern and program associate with the Cancer Support Community. With this background, Dr. Taw is able to provide information to participants about traditional Chinese medicine and how it can work with the treatments that someone may currently be undergoing.

Continued here:

Doctor to speak about integrative East-West medicine

Dr. Ron Noy, Sports Medicine , is named a Top Doctor: New York Metro Area

Posted on by

Dr. Ron Noy, a Board Certified New York, NYphysician specializing in Sports Medicine, has been selected by Castle Connolly Medical Ltd. for inclusion in its authoritative guide to the top primary care and specialty care doctors in the tri-state metropolitan New York area.

NEW YORK, March 14, 2013 /PRNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published the 16th edition of Top Doctors: New York Metro Area and has selected Ron Noy, MD for this exclusive honor.

(Photo: http://photos.prnewswire.com/prnh/20130314/DC77252)

The 16th edition of Top Doctors: New York Metro Area includes over 5,500 top primary care and specialty care physicians in a twenty-county area spanning three states: New York, New Jersey and Connecticut. Selected physicians, including Dr. Noy, represent the top 10% of doctors in the area in 65 medical specialties and subspecialties for the care and treatment of more than 1,800 diseases and medical conditions.

Castle Connolly Top Doctors are selected each year by Castle Connolly Medical Ltd. after being nominated by their peers in an online nomination process. Nominations are open to all board certified MDs and DOs and each year tens of thousands of physicians cast many tens of thousands of nominations. Nominated physicians are selected by the Castle Connolly physician-led research team based on criteria including medical education, training, hospital appointments, disciplinary histories and much more.

About Ron Noy: a short profile by and about the honoree:

Dr. Ron Noy, founder of Prestige Orthopaedics & Sports Medicine in midtown Manhattan, specializes in 4 arthroscopic knee and shoulder surgeries: ACL, meniscus, labrum, and rotator cuff. His reputation is getting his patients back to sports and work quicker with little or no post-operative pain. Dr. Noy sees every patient himself, giving a comprehensive examination. All patients have 24 hour access directly to Dr. Noy by cell and email. While Dr. Noy takes care of many professional athletes, musicians, actors and CEO's from all over the world, everyone is treated as a VIP.

For more information on this Castle Connolly New York Metro Area Top Doctor, please visitRon Noy's profile on http://www.castleconnolly.com.

Castle Connolly Medical Ltd.'s President and CEO Dr. John Connolly has this to say about Dr. Noy's recognition: "Roughly ten percent of area physicians were selected for our 16th edition of Top Doctors: New York Metro Area. Being nominated by Board Certified peers and then selected by our experts is an accomplishment worthy of recognition. The New York Metro area is home to a great number of very high quality medical professionals, yet some stand out. My congratulations to Dr. Noy."

To find out more or to contact Dr. Ron Noy ofNew York,NY, please call 646-862-0180, or visit http://www.PrestigeSportsMedicine.com.

See original here:

Dr. Ron Noy, Sports Medicine , is named a Top Doctor: New York Metro Area

The American Association of Colleges of Osteopathic Medicine Supports Bipartisan Legislation to Expand Medical …

Posted on by

WASHINGTON, DC--(Marketwire - Mar 14, 2013) - The American Association of Colleges of Osteopathic Medicine (AACOM) announces its support of the Training Tomorrow's Doctors Today Act, legislation introduced by U.S. Representatives Aaron Schock (R-IL) and Allyson Y. Schwartz (D-PA) to address the nation's physician workforce shortage and expand medical residency training positions in programs across the country.

"In the U.S. we are facing a significant physician shortage that will only increase in severity unless action is taken soon. Every eight seconds another Baby Boomer turns 65 so it's incumbent upon us to ensure we have a prepared physician workforce in place to meet the growing health care demands on our country," said Representative Schock. "The primary way our country can address the physician shortage is by ensuring we increase the number of Graduate Medical Education slots. By doing so, we are increasing the number of medical school graduates who will receive hands on training in a patient setting to gain the experience needed to become a practicing physician."

The Training Tomorrow's Doctors Today Act would increase the number of Medicare-funded graduate medical education (GME) positions by 3,000 each year, totaling 15,000 additional positions over the next five years. The legislation would give priority to hospitals in states with new medical schools and emphasize training in community-based settings. It would also require hospitals to train at least 30 percent of their residents in primary care and general surgery and require greater accountability and transparency by meeting specific performance measures.

The Balanced Budget Act of 1997, which currently is still in effect, capped the number of Medicare-funded residency positions. As osteopathic medical schools continue to graduate rising numbers of students, it is imperative to ensure that the number of medical residency positions increases simultaneously to continue training the nation's future physicians.

"The physician workforce shortage facing our nation, particularly in primary care, is a national crisis that requires comprehensive and cost-effective solutions," said AACOM President and CEO Stephen C. Shannon, D.O., M.P.H. "AACOM is pleased to offer its strong support of this critical legislation, which works to increase the training of the future physician workforce across the country while expanding access to patient care. AACOM commends Representatives Schock and Schwartz for their unwavering leadership on this issue."

About AACOMAACOM represents the nation's 29 colleges of osteopathic medicine at 37 locations in 28 states. Today, more than 21,000 students are enrolled in osteopathic medical schools. One in five U.S. medical students is training to become an osteopathic physician.

AACOM was founded in 1898 to support and assist the nation's osteopathic medical schools, and to serve as a unifying voice for osteopathic medical education. AACOM's mission is to promote excellence in osteopathic medical education, in research and in service, and to foster innovation and quality among osteopathic medical colleges to improve the health of the American public.

View original post here:

The American Association of Colleges of Osteopathic Medicine Supports Bipartisan Legislation to Expand Medical ...

New ReadyGO Donor Egg Cycle Program Launched By Reproductive Medicine Associates Of New Jersey

Posted on by

BASKING RIDGE, N.J., March 13, 2013 /PRNewswire/ --Reproductive Medicine Associates of New Jersey, today announced the introduction of its new ReadyGO Donor Cycle Guarantee program designed to give couples faster access to donor eggs and multiple chances at IVF pregnancy success. Offered in partnership with NW Cryobank, a leader in frozen egg banking services based in Spokane, Washington, the ReadyGO program covers up to three withdrawals from NW Cryobank and the transfer of all embryos created from those eggs until a live birth is achieved. Should no live birth be achieved after all embryos created are transferred, a patient will receive a refund totaling about 80% of their initial outlay.

(Logo: http://photos.prnewswire.com/prnh/20120402/NY80340LOGO)

"ReadyGO was designed for donor recipients looking to cycle faster than a traditional fresh-donor approach, for which average wait lists can run nine months or more," said Thomas J. Kim, MD, FACOG, Director, Third Party Reproduction. "With the ReadyGO package, a patient can begin trying as early as her next cycle."

Added Dr. Kim, "ReadyGO offers a safe and effective path to pregnancy which can be put into place quickly and offers financial protection. A patient can undergo multiple cycles until a live birth is achieved, or until all embryos are transferred, for a single price."

"We are excited to partner with RMANJ to give patients participating in their donor egg program a faster solution to expand their family," said Tammy Zimmer, MT (ASCP), Managing Director, NW Cryobank. "Eggs from our donors listed on the NW Cryobank website are available immediately for donor recipients. All egg donors at NW Cryobank are medically, genetically and psychologically screened to ensure the best possible outcomes as part of the ReadyGO Donor Cycle Guarantee."

About ReadyGO Through the new program, patients are able to pay a package price which covers up to three withdrawals from NW Cryobank and the transfer of all embryos created from those eggs until a live birth is achieved. With RMANJ single cycle delivery rates in the 60% range (www.sart.org), many ReadyGO patients will achieve pregnancy in one cycle. Their cost at that point will have run about 35% more than a traditional "pay as you go" donor cycle, but they will have shortened their time to cycle by as many as nine months or more. If pregnancy is not achieved during the first cycle attempted, a patient can move quickly to the next cycle; after two attempts the cumulative delivery rates approach 80% and there is a cost savings over the "pay as you go" method of about 30%. If a third cycle is needed, patients have a greater than 85% chance of delivery at approximately half the cost of three "pay as you go" cycles. Should live birth not be achieved after all embryos created are transferred, a patient will receive a refund totaling about 80% of their initial outlay.

ReadyGO cannot be combined with insurance. Additional costs for medications and other service fees such as anesthesia may still apply. For more information, visit http://www.rmanj.com/readygo.

About Reproductive Medicine Associates of New Jersey Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and ultimately healthy babies. Other centers have attempted similar testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research. RMANJ's Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.

The fertility experts at RMANJ have among the highest IVF success rates in the country. Since 1999, they have helped bring nearly 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has seven locations in New Jersey. For more information please call RMANJ at 973-656-2089, or visit http://www.rmanj.com.

See the original post here:

New ReadyGO Donor Egg Cycle Program Launched By Reproductive Medicine Associates Of New Jersey

Japan’s herbal medicine industry worries as China restricts licorice supplies

Posted on by

By Hironari Akiyama The Yomiuri Shimbun/Asia News Network Thursday, Mar 14, 2013

Companies making Chinese herbal medicine are stepping up efforts to ensure a stable supply of licorice, a major raw material for the medicine whose import price has increased by about 50 per cent over the past five years.

The price rise is due to tightened regulations on the harvest and export of licorice (kanzo in Japanese) imposed by leading licorice producer China for resource protection reasons.

The expectation of further reductions in licorice imports has led to the expansion of domestic licorice cultivation.

Licorice, a kind of legume, accounts for about 70 per cent of the raw material in as many as 500 kinds of Chinese herbal medicine. Licorice is considered a "rare plant" for which high-volume cultivation is difficult. More than 90 per cent of the licorice used for Chinese herbal medicine in Japan is imported from China.

There is increasing global demand for Chinese herbal medicine, especially as interest in oriental medicine grows in the United States and Europe.

In 2000, the Chinese government began controlling the harvest and export of the plant to prevent desertification in licorice vegetation areas due to overharvesting.

Since Japan imports licorice for Chinese herbal medicine production almost entirely from China, there has been concern that deteriorating relations between Tokyo and Beijing over the Senkaku Islands may adversely affect imports.

Chinese herbal medicine makers are stepping up efforts to boost stockpiles of Chinese licorice. Tsumura & Co., one of the largest Chinese herbal medicine makers, has secured about two years' supply of the plant.

A movement to grow the plant in Japan also has become active. Fukuoka-based midsize pharmaceutical company Shin Nihon Iyaku Corp. is aiming to grow its own licorice to use as raw material for Chinese herbal medicine on a large scale, following confirmation in February that the licorice it grew on an experimental basis in idle rice fields contains an important active ingredient.

More here:

Japan's herbal medicine industry worries as China restricts licorice supplies

Modern medicine ’s puzzling

Posted on by

Cindy Adams

Skin your knee? Got a boo-boo? Shove the salve. Poo on the pharmacist. Would Noah wait in his dermatologists cave office because of a zebra bite?

While picking the apple for Adam, suppose that snake bit Eve. Minus a friendly neighborhood druggist to unload a $75 unguent, shed have had to shop in the Garden of Eden. Scientific and medical restrictions would ban that today. Could be poison ivy. Shed need Benadryl. Shed need antihistamine. Veggies have pesticides. The kid Abel could contract zxppqycbvyiitis. And our health department would prescribe zip-lofan panxcroderm ziplozinc.

The old days did bush medicine. Rub with garlic. The Medecine Mans prescription read: Got a scrape? Get a clove. Youd smell, but you were healed. Also good for bites. Insect bites. Dog bites. Husband bites.

For piercing our ears, my grandma from the old country said: Saliva. Mouth to fingers to lobe. Perfect. Now? Antibiotics. Then a doc feels your purse and says, Nothing I can do.

Body ache. Tea from tall skinny fever grass weed. Boil in lukewarm water. And bathe your skin in it. Three days, youre fine. Also clean. Tell an internist: Every bone in my body hurts. Hell say: Be glad youre not a herring. Next.

Skin allergy. Stuff the salve. Boil a certain thick bark. Drink. No more allergy. The physicians regimen? Dont drink, eat, smoke, dissipate or do anything to interfere with paying my bill.

Fever. Boil cinnamon and clove. Drink often. Heats the body. Kills germs. Also kills off those MDs who once hit house calls Monday and golf clubs Wednesday.

Newborns. Midwives. Lay on the ground, palms pressed against a wall behind you. Twice a day for five days heal the bellybutton cord with warm coconut oil. The antiseptic? Rum.

Before Lipitor, what antediluvians did for high cholesterol, I dont know. Maybe tuna tartare with radicchio on a bed of chanterelles, shiitakes and portobellos. Mushrooms fight body fat. What they do for cholesterol, who knows?

Read more here:

Modern medicine ’s puzzling

Stony Brook Medicine Receives $750,000 Pledge From Charles Gargano For Endowed Chair In Advanced Cardiovascular Imaging

Posted on by

STONY BROOK, N.Y., March 14, 2013 /PRNewswire/ --Charles A. Gargano, former U.S. Ambassador to Trinidad and Tobago and long-time friend of Stony Brook University, has agreed to establish the Ambassador Charles Gargano Chair in Advanced Cardiovascular Imaging at Stony Brook Medicine.

The $750,000 gift will be matched dollar for dollar by the Simons Foundation Challenge and Jim and Marilyn Simons, creating a $1,500,000 philanthropic impact. The funds will be used to attract an accomplished, research-oriented scientist and clinician who is dedicated to finding new methods of diagnosis and treatment. The holder will serve as an institutional leader in advanced cardiovascular imaging. Generous funding will enable staff to conduct research using imaging tools and working with the clinical population.

Though he is not a graduate of Stony Brook, Gargano has supported the University for many years. He helped establish a Chair and a Center for Italian Studies more than 25 years ago, and in 2005 he received an honorary doctorate from Stony Brook University to honor both his accomplishments and his generosity.

"I lived on Long Island for many years, and my professional career was on Long Island before I went into the world of politics," explained Gargano. "I have always thought of Stony Brook as an important institution. Recently, I have been impressed with the work of Stony Brook's Dr. Michael Poon, who inspired me to make my latest gift."

World-renowned cardiologist and imaging specialist Michael Poon, MD, came to Stony Brook in 2009, becoming Director of Advanced Cardiovascular Imaging at Stony Brook University Hospital and Professor of Radiology and Medicine (Cardiology) at Stony Brook University School of Medicine. Dr. Poon is one of the pioneers who helped develop CT imaging technologies to "photograph" the heart in motion, giving Emergency Room doctors the ability to more quickly and accurately diagnose the causes of chest pain. At Stony Brook, Dr. Poon literally changed the Emergency Room paradigm by recognizing the importance of advanced cardiac imaging.

"I saw that Dr. Poon's work related not only to better outcomes for people who present in Emergency Rooms with chest pain but also to cost savings and better efficiency for hospitals and congested Emergency Rooms," said Gargano, adding that Stony Brook University Hospital is making tremendous strides not only in imaging and cardiology, but also in cancer research and more. "The hospital is growing and is becoming increasingly more important to the people of Long Island."

"Ambassador Gargano has been a valued friend of the University for many years," said President Samuel L. Stanley Jr., MD. "This latest expression of his trust and confidence in our ability to advance the science of cardiovascular imaging is tremendously gratifying, and we will put his investment to good use right away."

Gargano has long been a champion of economic development and public service. Before becoming active in politics, he served as a construction engineer and a principal at the New York/New Jersey-based J.D. Posillico Engineering and Construction. He was appointed as Deputy Administrator of the Federal Urban Mass Transportation Administration in 1981, and then as Ambassador to Trinidad and Tobago, serving from 1988 to 1991. He was the Chairman and Commissioner of Empire State Development and also served as a Vice Chairman of Port Authority of New York and New Jersey from 1995 to 2007.

"Federal funding for research is dwindling," said Vice President for University Advancement Dexter Bailey. "We very much rely on the generosity of people like Ambassador Gargano--people who want to help society by supporting new ideas, new research, new technology, and the innovators who will provide solutions to great health challenges. The Gargano Chair in Advanced Cardiovascular Imaging is critically important, giving us the ability to continue to find ways to save lives, and we couldn't be more grateful."

Ultimately, Gargano hopes others will join him in reaching the $750,000 endowment goal. "Prospective donors who participate in this great opportunity will be helping advance cardiac imaging, which is such an important part of understanding and diagnosing individuals' problems," he explained. "Today it might be someone else, but tomorrow it might be ourselves. Private philanthropy is very important because it is the primary way for people to demonstrate their support for causes that matter to them. The Chair at Stony Brook is one of those important causes, and I hope Dr. Poon's work will inspire others."

Read the original post:

Stony Brook Medicine Receives $750,000 Pledge From Charles Gargano For Endowed Chair In Advanced Cardiovascular Imaging

Research and Markets Announces the Release of ‘Personalized Medicine – A Global Market Overview’

Posted on by

DUBLIN, March 14, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vghldf/personalized) has announced the addition of the "Personalized Medicine - A Global Market Overview" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report reviews, analyzes and projects the personalized medicine market for global and the regional markets including the United States, Europe and Rest of World. The market numbers illustrated in this report only represent the market exclusively for the product segments and technologies enunciated above. The market, in this report, does not include the associated hardware equipment or software technologies that are used to manage patient data. The study includes recent and current trends related to technology and the market along with the key industry developments.

The market for personalized medicine product types analyzed in this study includes Targeted Biologics, Proteomics & Genomics, Genetically Modified (GM) Products, Wellness & Disease Management, Other Molecular Diagnostics and Self/Other Diagnostics. The report also includes the market analysis for application technologies of personalized medicine - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies. The report analyses the global market in terms of USD Million.

This 350 page global market report includes 43 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and application technology.

The report covers the brief business profiles of 56 key global players and 77 major players across the United States - 45; Europe - 24; and Rest of World - 8.

The report also provides the listing of the companies engaged in research and development, manufacturing, processing, supplies and distribution of personalized. Also enlisting the academic institutions engages in personalized medicine, the global list covers the addresses, contact numbers and the website addresses of 395 companies.

For more information, including table of contents and list of companies mentioned, please visit http://www.researchandmarkets.com/research/vghldf/personalized

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices

Excerpt from:

Research and Markets Announces the Release of 'Personalized Medicine - A Global Market Overview'

Medical School – Hypoxemia: Alveolar – Arterial Oxygen Gradient Made Simple – Video

Posted on by


Medical School - Hypoxemia: Alveolar - Arterial Oxygen Gradient Made Simple
Discussion of the Alveolar - arterial oxygen gradient in evaluating hypoxemia. Hypoxemia has five main causes which we discuss. It is important to understand...

By: iMedicalSchool

Read more:

Medical School - Hypoxemia: Alveolar - Arterial Oxygen Gradient Made Simple - Video

Bill would add 40 slots at U. medical school

Posted on by

Bill would add 40 slots at U. medical school

The University of Utah Medical School is on course to add 20 new slots for students in the coming year and 20 more the following year under a bill moving through the Legislature.

The new positions will cost $6.5 million in the first year and a total of $10 million in the second phase, bringing the total number of medical students in the program to 122.

"Access to this sort of knowledge is a precious commodity. Its an expensive commodity, Ill grant you that, but its precious," said Rep. Michael Kennedy, R-Alpine, who is a doctor. "More important than that is the ability to take this knowledge and use it for the benefit of our citizens."

The bill passed the House 70-4. The Senate still has to agree to an amendment added to the House staggering the 40 new slots before the bill goes to the governor.

Robert Gehrke

Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Original post:

Bill would add 40 slots at U. medical school

Hopkins medical school falls to No. 3 in U.S. News rankings

Posted on by

Johns Hopkins University's medical school fell one spot to No. 3 in the nation, while its education school rose to No. 2, according to the latest U.S. News and World Report graduate school rankings.

The medical school ranked behind those of Harvard University and Stanford University among the top institutions for medical research. University of Maryland School of Medicine ranked No. 37.

Other Maryland institutions to rank among the top 10 in their disciplines were the University of Maryland, Baltimore's Francis King Carey School of Law's part-time program, the University of Maryland, College Park's library sciences school, Johns Hopkins' public health and nursing schools and the Maryland Institute College of Art's fine arts program.

The rankings appeared in the magazine's 2014 Best Graduate Schools Rankings released Tuesday. Ranking criteria vary by discipline, but are generally based on admissions selectivity and expert opinions on program quality, according to a U.S. News news release.

The medical school rankings weigh in assessments by peer academic officials and residency program directors, research activity in total and per faculty member, admissions selectivity, students' MCAT scores and undergraduate GPAs, and student-to-faculty ratios.

"We consider it an honor to be consistently ranked among the very top medical schools in the nation," Hopkins spokeswoman Ellen Beth Levitt said. "Small point differences from year-to-year can account for changes in a school's specific ranking."

The education school at Hopkins rose four spots to lag behind only Vanderbilt University for its graduate studies. That was after rising from No. 18 to No. 6 in the 2013 rankings. The education school launched as its own entity in 2007, housed before that along with what is now the university's Carey Business School.

Maryland programs appeared on the following lists:

Engineering: University of Maryland, College Park, down one spot to No. 19; Johns Hopkins, up one spot to No. 25.

Business: University of Maryland, College Park, No. 37.

The rest is here:

Hopkins medical school falls to No. 3 in U.S. News rankings

How to Fast Track Medical School

Posted on by

When Robert Cooper was growing up in Edgewood, Texas, he liked his neighborhood family doctor so much that by the time he got into medical school in 2010, he already knew he wanted to go into primary care.

"I used to always go to our family practice physician, so that's what I knew," says Cooper, 26, who also values "the flexibility of being able to work in a rural area."

It didn't hurt, either, that primary care doctors are so in demand that his medical school is speeding them into the workforce. The program Cooper enrolled in, an accelerated option at Texas Tech University Health Sciences Center School of Medicine in Lubbock, will allow him to get his medical degree in three years rather than the usual four, provided he commits to primary care.

[Find out if primary care is right for you.]

"We have a shortage of physicians, particularly in primary care," says John Prescott, chief academic officer of the Association of American Medical Colleges in Washington, D.C., which projects the nation will have 45,000 too few primary care doctors by 2020. "This is one step forward in helping to alleviate that. I think we'll see other schools looking closely at this."

The school of medicine at Mercer University in Savannah, Ga., already offers a similar three-year M.D. degree, and Lake Erie College of Osteopathic Medicine in Erie, Pa., offers a three-year program for osteopaths who have chosen family medicine and general internal medicine.

[Read about changes in medical residency training.]

How do you cram four years of intense learning into three? At Texas Tech and Mercer, the key is shortening the clinical rotations medical students experience to get trained in other specialties and focusing instead most of their real-world experience on family medicine.

"One of the reasons we can do this is a lot of the fourth year is elective--trying to decide what you want to go into, and doing audition rotations around the country," says Steven Berk, dean of the Texas Tech medical school. "The various competencies that are normally covered in the fourth year we cover in eight weeks."

That condensed schedule offers financial rewards, notes Robert Pallay, residency director and chair of family medicine at Mercer. Students "pay one year less of tuition, which saves $40,000 to $50,000," he says. "They get out a year earlier, so rather than making $50,000 as a resident, they [may] end up earning $200,000-plus as a regular doctor."

Visit link:

How to Fast Track Medical School

MEDICAL SCHOOL : Medina, Roth urge $15 million in budget

Posted on by

Posted on | March 14, 2013 | Comments

State Sen. Richard Roth, D-Riverside, and Assemblyman Jose Medina, D-Riverside (Senate photo)

No votes were taken and no promises were made. But a pair of Riverside Democrats made their case Thursday to Senate budget writers that the 2013-14 spending plans needs to include $15 million for UC Riversides medical school.

Assemblyman Jose Medina and state Sen. Richard Roth, both Riverside Democrats elected in November, said the schools future depends on the state appropriating the money. Riverside County and other donors already have committed $18 million to the school.

Without the $15 million were talking about today, the community commitments associated with that may dry up, the preliminary accreditation that the medical school received will be pulled undoubtedly and the school will fail, Roth told the education subcommittee of the Senate Budget and Fiscal Review Committee.

Each of the panels three members seemed to agree on the need for the school in the medically underserved Inland region but all stepped well short of pledging to support spending state money on it.

If I had it, it would be an easy call, said state Sen. Rod Wright, D-Inglewood. I dont think we have $15 million just sitting around unspent.

Roth and Medina are the latest Inland lawmakers to lobby for medical school money. In past years, state Sen. Bill Emmerson, Assemblyman Brian Nestande, and former Inland lawmakers Bob Dutton, John Benoit, Jeff Miller, Denise Moreno Ducheny and helped carry the schools water in Sacramento.

By: Jim Miller

Comments

Read more:

MEDICAL SCHOOL : Medina, Roth urge $15 million in budget